Aims: Inhaled nebulised unfractionated heparin (UFH) has a strong scientific and biological rationale that warrants urgent investigation of its therapeutic potential in patients with COVID-19. UFH has antiviral effects and prevents the SARS-CoV-2 virus' entry into mammalian cells. In addition, UFH has significant anti-inflammatory and anticoagulant properties, which limit progression of lung injury and vascular pulmonary thrombosis. Methods: The INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP) metatrial is a prospective individual patient data analysis of on-going randomised controlled trials and early phase studies. Individual studies are being conducted in multiple countries. Participating studies randomise adult patients admitted to the hospital with confirmed SARS-CoV-2 infection, who do not require immediate mechanical ventilation, to inhaled nebulised UFH or standard care. All studies collect a minimum core dataset. The primary outcome for the metatrial is intubation (or death, for patients who died before intubation) at day 28. The secondary outcomes are oxygenation, clinical worsening and mortality, assessed in time-to-event analyses. Individual studies may have additional outcomes.Analysis: We use a Bayesian approach to monitoring, followed by analysing individual patient data, outcomes and adverse events. All analyses will follow the intention-to-PI Statement: The authors confirm that the PI for this paper is Professor Frank M.P. van Haren and that he has direct responsibility for the described metatrial. Metatrial Combined Protocol and Statistical Analysis Plan date and version: 14 December 2020, INHALE-HEP metatrial version 2.0.

The identification and classification of species are essential for effective conservation management. This year, Australia experienced a bushfire season of unprecedented severity, resulting in widespread habitat loss and mortality. As a result, there has been an increased focus on understanding genetic diversity and structure across the range of individual species to protect resilience in the face of climate change. The greater glider (Petauroides volans) is a large, gliding eucalypt folivore. This nocturnal arboreal marsupial has a wide distribution across eastern Australia and is considered the sole extant member of the genus Petauroides. Differences in morphology have led to suggestions that the one accepted species is actually three. This would have substantial impacts on conservation management, particularly given a recent history of declining populations, coupled with extensive wildfires. Until now, genetic evidence to support multiple species has been lacking. For the first time, we used DArT sequencing on greater glider tissue samples from multiple regions and found evidence of three operational taxonomic units (OTUs) representing northern, central and southern groups. The three OTUs were also supported by our morphological data. These findings have important implications for greater glider management and highlight the role of genetics in helping to assess conservation status.

No abstract